AMBENYL Drug Patent Profile
✉ Email this page to a colleague
When do Ambenyl patents expire, and what generic alternatives are available?
Ambenyl is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in AMBENYL is bromodiphenhydramine hydrochloride; codeine phosphate. There are two drug master file entries for this compound. Additional details are available on the bromodiphenhydramine hydrochloride; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMBENYL?
- What are the global sales for AMBENYL?
- What is Average Wholesale Price for AMBENYL?
Summary for AMBENYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Patent Applications: | 5,196 |
| DailyMed Link: | AMBENYL at DailyMed |
US Patents and Regulatory Information for AMBENYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | AMBENYL | bromodiphenhydramine hydrochloride; codeine phosphate | SYRUP;ORAL | 009319-006 | Jan 10, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
